IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v13y2016i3p290-d65165.html
   My bibliography  Save this article

A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder

Author

Listed:
  • Fabio Caputo

    (Department of Internal Medicine, SS Annunziata Hospital, Cento, Ferrara 44042, Italy
    “G. Fontana” Centre for the Study and Multidisciplinary Treatment of Alcohol Addiction, Department of Clinical Medicine, University of Bologna, Bologna 40130, Italy)

  • Teo Vignoli

    (Unit for Addiction Treatment, Department of Mental Health, Lugo, Ravenna 48022, Italy)

  • Claudia Tarli

    (Alcohol Use Disorders Unit, Department of Internal Medicine, Catholic University of Rome, Rome 00168, Italy)

  • Marco Domenicali

    (“G. Fontana” Centre for the Study and Multidisciplinary Treatment of Alcohol Addiction, Department of Clinical Medicine, University of Bologna, Bologna 40130, Italy)

  • Giorgio Zoli

    (Department of Internal Medicine, SS Annunziata Hospital, Cento, Ferrara 44042, Italy)

  • Mauro Bernardi

    (“G. Fontana” Centre for the Study and Multidisciplinary Treatment of Alcohol Addiction, Department of Clinical Medicine, University of Bologna, Bologna 40130, Italy)

  • Giovanni Addolorato

    (Alcohol Use Disorders Unit, Department of Internal Medicine, Catholic University of Rome, Rome 00168, Italy)

Abstract

The treatment of alcohol use disorder (AUD) with sodium oxybate (SMO) or gamma-hydroxybutyric acid (GHB) was introduced in Italy and Austria more than 20 years and 15 years ago, respectively, and it is now widely employed to treat alcohol withdrawal syndrome (AWS) and to maintain alcohol abstinence. These indications derive from its similar structure to the inhibitory neurotransmitter γ-amino-butyric acid (GABA), exerting an ethanol-mimicking effect, because it binds to GABA B receptors. Craving for, and abuse of, SMO remain a controversial issue; even though these unfavorable effects are evident in poly-drug addicted patients and in those with psychiatric diagnosis of borderline personality disorder. In addition, despite cases of severe intoxication and deaths being widely documented when GHB is used as “street drug”; its clinical use remains safe. Thus, the aim of the present review is to examine the role of SMO in the treatment of AUD, its possible implications in reducing alcohol consumption, and cases of abuse, and severe intoxication due to SMO during its clinical use in the treatment of AUD.

Suggested Citation

  • Fabio Caputo & Teo Vignoli & Claudia Tarli & Marco Domenicali & Giorgio Zoli & Mauro Bernardi & Giovanni Addolorato, 2016. "A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder," IJERPH, MDPI, vol. 13(3), pages 1-6, March.
    • Handle: RePEc:gam:jijerp:v:13:y:2016:i:3:p:290-:d:65165
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/13/3/290/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/13/3/290/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:13:y:2016:i:3:p:290-:d:65165. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.